Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of ClearLLab LS Screening Panel for the Diagnosis of Hematological Malignancies

NCT05819762 is registered in ClinicalTrials.gov with Beckman Coulter, Inc. as lead sponsor.

NCT NCT05819762
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05819762 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of ClearLLab LS Screening Panel for the Diagnosis of Hematological Malignancies
Lead sponsor
Beckman Coulter, Inc.
Phase
Observational
Overall status
Completed
Start date
May 25, 2023
Completion date
November 18, 2024
Enrollment
831 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

hematologic diseases, hematologic malignancy, hematologic neoplasms